Clinical Trial Update: Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial investigating recombinant human glutamic acid decarboxylase (GAD) for progression in new-onset Type 1 Diabetes; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• recombinant human glutamic acid decarboxylase (glutamic acid decarboxylase)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2016-12-07